Karamvir Yadav on Sara Tolaney Study Examining pCR Versus Stage
Karamvir Yadav and Sara Tolaney

Karamvir Yadav on Sara Tolaney Study Examining pCR Versus Stage

Karamvir Yadav, Medical Oncologist in Jaipur, India, shared posts on X:

“Impact full article Sara Tolaney.

Is pCR enough to override stage? This study suggests: YES (largely).

But only if pCR is achieved. Otherwise: cT3-4, cN+, TNBC – worse outcomes Response-guided oncology is the future.”

Karamvir Yadav

Title: Impact of pathologic response and individual prognosis after neoadjuvant treatment in patients with early HER2+ and triple-negative breast cancer

Authors: Chiara Corti, Tianyu Li, Alyssa R. Martin, Melissa E. Hughes, Tonia Parker, Tyzaire S. DuPorte, Giuseppe Curigliano, Tari A. King, Elizabeth A. Mittendorf, Nancy U. Lin, Nabihah Tayob, Sara M. Tolaney

Read The Full Article

Karamvir Yadav

Other articles about pCR on OncoDaily.